Chronic heart failure: Interventions and outcomes

Disease Management and Health Outcomes

Volumn 1, Issue 4, 1997, Pages 185-196

  Staniforth, Andrew D ^a,c   Cowley, Alan J ^a,b,c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344223685     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199701040-00002     Document Type: Article

References (51)

1. Schocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6
2. McMurray J, McDonagh T, Morrison CE, et al. Trends in hospitalisation for heart failure in Scotland 1980-1990. Eur Heart J 1993; 14: 1158-62
3. Ho KKL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A
4. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993; 22: 14A-19A
5. McMurray J, Hart W. The economic impact of heart failure on the UK National Health Service. Eur Heart J 1993; 14 Suppl.: 133
6. Hart W, McMurray J. The cost-effectiveness of enalapril in the treatment of heart failure. Eur Heart J 1993; 14 Suppl.: 14
7. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J General Pract 1996; 46: 77-9
8. Houghton AR, Cowley AJ. Effectiveness of a specialist clinic in managing heart failure. J R Coll Physicians Lond. In press
9. Francis CM, Caruana L, Kearney P, et al. Open access echocardiography in management of heart failure in the community. BMJ 1995; 310: 634-6
10. Davie AP, Francis CM, Love MP, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996; 312: 222
11. Taylor SH. Refocus on diuretics in the treatment of heart failure. Eur Heart J 1995; 16 Suppl. F: 7-15
12. Cowley AJ, Stainer K, Wynne RD, et al. Symptomatic assessment of patients with heart failure: double blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986; II: 770-2
13. Grinstead WC, Francis MJ, Marks GF, et al. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73: 881-6
14. Pitt B. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES). Eur Heart J 1995; 16 Suppl. N: 107-10
15. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Co-operative Study (V-HeFT). N Engl J Med 1986; 314: 1547-52
16. Cohn JN, Johnson G, Ziesche S, et al. A comparison of Enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10
17. Walsh JT, Andrews R, Cowley AJ. Effects of amlodipine in chronic heart failure. Am Heart J. In press
18. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-14
19. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe heart failure. N Engl J Med 1987; 316: 1429-35
20. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 295-302
21. Rogers WJ, Johnstone DE, Yusuf S, et al. Quality of life among 5025 patients with left ventricular dysfunction randomised between placebo and enalapril: SOLVD. J Am Coll Cardiol 1994; 23: 393-400
22. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91
23. Cowley AJ, Hampton JR, Rowley JM, et al. Abnormalities of peripheral circulation and respiratory function in patients with severe heart failure. Br Heart J 1986; 55: 75-80
24. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial dysfunction. N Engl J Med 1992; 327: 669-77
25. The AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8
26. Kober L, Torp-Pederson C, Carlsen JE, et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-6
27. The ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected myocardial infarction. Lancet 1995; 345: 669-84
28. GISSI-3 Collaborators. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-22
29. Flather M. From infarct to failure: meta-analysis of ACE-inhibitor trials in myocardial infarction. Oral presentation at 18th Congress of European Society of Cardiology: 1996 Aug 25-29; Birmingham
30. Benedict C, Rousseau M, Bourassa M, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173-8
31. MERCATOR Study Group. Does the new angiotensin convening enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal angioplasty? Circulation 1992; 86: 100-10
32. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 1996; 94: 258-65
33. Texter M, Lees RS, Pitt B, et al. The Quinapril Ischaemic Event Trial (QUIET). Cardiovasc Drugs Ther 1993; 7: 273-82
34. The NETWORK Investigators. The NETWORK study: the effect of dose of an ACE inhibitor on outcome in patients with heart failure. Heart 1996; 75 Suppl.: P54
35. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-6
36. CIBIS Investigators. A randomised trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study. Circ 1994; 90: 1765-73
37. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-55
38. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of Carvedilol in patients with moderate-severe heart failure: the PRECISE Trial. Circulation 1996; 94: 2793-9
39. Cowley AJ, Skene AM. Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Br Heart J 1994; 72: 226-30
40. Packer M, Rouleau J, Swedberg K, et al. Effect of flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study. Circulation 1993; 88: 1-301
41. Hampton JR, Van Veldhuisen DJ, Kleber FX, et al. Randomised study of the effect of ibopamine on survival in patients with advanced severe heart failure. Lancet 1997; 349: 971-7
42. Feldman A, Young J, Bourge R, et al. Mechanism of increased mortality from vesnarinone in the severe heart failure trial (VesT). J Am Coll Cardiol 1997; 29 Suppl. A: 64A
43. Uretsky BF, Young JB, Shahidi E, et al. Randomised study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955-62
44. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993; 329: 1-7
45. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-32
46. Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-8
47. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82
48. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12
49. Newman D, Sauve MJ, Herre J, et al. Survival after implantation of the cardiac defibrillator. Am J Cardiol 1992; 69: 899-903
50. Pitt B, Segal R, Martinez FA, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE). Lancet 1997; 349: 747-52
51. O'Connell JB, Breen TJ, Hosenpud JD. Heart transplantation in dilated heart muscle disease and myocarditis. Eur Heart J 1995; 16 Suppl. O: 137-9